News and Press Releases
European Commission Approves ADCETRIS (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
· Approval Based on Updated Positive Overall Survival Results from the phase 3 ECHELON-1 Study for Stage III & IV Hodgkin Lymphoma · First Significant Improvement in Overall Survival in Two Decades...
Category: Pharmaceutical
Posted: October 23, 2023
Sonrai Analytics Receives ISO 13485 Certification for Medical Device Development
The certification is a step towards commercialising Sonrai’s AI diagnostic platform to aid pathologists in analysing cancerous cells from pathology images 19 October 2023 -- Belfast, Northern Ireland -- Sonrai...
Category: Other
Posted: October 19, 2023
Whitla Medical Building, 97 Lisburn Road, Belfast, BT9 7BL
Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases
World-leading CDMO Offers Highly Specialised Experience Bringing Complex Formulations to Market Quickly and Will Support Clinical Trials of Aldena’s siRNA-based Injectable Treatment 19 October 2023 –Philadelphia, US -- Aldena Therapeutics,...
Category: Clinical Trials, Drug Discovery
Posted: October 19, 2023
Etihad Cargo Enhances US Cool Chain Capabilities with WFS Partnership
Etihad Cargo has boosted its cool chain capabilities in the US, expanding its network with Worldwide Flight Services (WFS) to include Chicago O'Hare International Airport (ORD) in addition to John...
Category: Logistics
Posted: October 19, 2023
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science 18 October 2023 -- Boston, US and Rolle, Switzerland --...
Category: Biotechnology
Posted: October 19, 2023
New £30m Initiative to Address Global Threat by Accelerating the Pace of Antimicrobial Innovation
Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050 19 October 2023 -- Swindon,...
Category: Other
Posted: October 19, 2023
Vetter looks ahead to further expansions to meet supply chain demand
Committed to sustainable growth and long-term planning ▪ Dedicated to making investments to support increased customer demand▪ Maintain efficiency and quality in development and manufacturing processes 17 October 2023 --...
Category: Manufacturing and Packing
Posted: October 18, 2023
Broken String Biosciences’ INDUCE-seq platform demonstrates impact of structural DNA changes on specificity of CRISPR-Cas9 gene editing
Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform,...
Category: Biotechnology
Posted: October 18, 2023
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
Semarion announces Early Adopter Programme for SemaCyte Microcarrier Platform
SemaCyte Microcarrier Platform addresses limitations within adherent cell assays to accelerate the pace of in vitro drug discovery Early access will further validate the technology and provide feedback on applicability...
Category: Biotechnology
Posted: October 18, 2023
Mundipharma and Cidara Therapeutics receive positive CHMP opinion forrezafungin for the treatment of Invasive Candidiasis in adults
The opinion was based on positive results from the pivotal ReSTORE phase 3 clinicaltrial and supported by the STRIVE phase 2 clinical trials and extensive nonclinicaldevelopment programme If approved by...
Category: Biotechnology
Posted: October 17, 2023
PharmaKure announces study success for novel blood test to identify biomarkers in patients with Alzheimer’s Disease
Study confirms ALZmetrix whole blood test can detect people at high risk of developing full Alzheimer’s Disease 17 October 2023 -- Manchester, UK -- PharmaKure, a pharmaceutical company spun out...
Category: Clinical Trials, Drug Discovery
Posted: October 17, 2023
Alderley Park Congleton Road Nether Alderley Open Access Lab 19S6 Macclesfield SK10 4TG
pharmaand GmbH Receives Positive CHMP Opinion for Rubraca (rucaparib) as a First-Line Maintenance Treatment in Advanced Ovarian Cancer
CHMP positive opinion based on the results from Phase 3 ATHENA-MONO trial European Commission (EC) approval decision expected in the coming months This is the first rucaparibregulatory milestone since being...
Category: Pharmaceutical
Posted: October 17, 2023
Gilead and Kite Oncology Present Important Data Across Multiple Difficult-to-Treat Cancers at ESMO Congress 2023
– Real-World Evidence and New Clinical Analysis Support the Role of Trodelvy (sacituzumab govitecan-hziy) in Metastatic Breast Cancers – New Data Demonstrate Potential of Sacituzumab Govitecan in Small Cell Lung...
Category: Pharmaceutical
Posted: October 16, 2023
KFSH&RC Announces Strategic Partnership with the Global Health Exhibition
16 October 2023 -- Riyadh, Saudi Arabia -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) plays a critical role in the upcoming Global Health Exhibition 2023, a major event...
Category: Other
Posted: October 16, 2023
Makkah Al Mukarramah Branch Rd, Al Mathar Ash Shamali Saudi Arabia
Antiverse and GlobalBio, Inc extend collaboration to advance antibody cancer therapeutics
Collaboration successfully identified antibodies with therapeutic potential as checkpoint inhibitors in oncology Two antibodies showing high specificity for PD-1 are now being progressed to preclinical development Project leveraged Antiverse’s AI-driven...
Category: Biotechnology
Posted: October 16, 2023
